84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]胡海,豐凡翔,雷孝勇,等.中醫(yī)藥治療股骨頭壞死的常用藥物分析[J].中醫(yī)正骨,2016,28(08):24-26.
 HU Hai,FENG Fanxiang,LEI Xiaoyong,et al.Analysis of drugs commonly used in TCM therapy for treatment of osteonecrosis of the femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):24-26.
點(diǎn)擊復(fù)制

中醫(yī)藥治療股骨頭壞死的常用藥物分析()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第28卷
期數(shù):
2016年08期
頁(yè)碼:
24-26
欄目:
文獻(xiàn)研究
出版日期:
2016-08-20

文章信息/Info

Title:
Analysis of drugs commonly used in TCM therapy for treatment of osteonecrosis of the femoral head
作者:
胡海豐凡翔雷孝勇徐祖健
西南醫(yī)科大學(xué)附屬中醫(yī)醫(yī)院,四川 瀘州 646000
Author(s):
HU HaiFENG FanxiangLEI XiaoyongXU Zujian
The TCM Hospital Affiliated to Southwest Medical University,Luzhou 646000,Sichuan,China
關(guān)鍵詞:
股骨頭壞死 中藥療法 補(bǔ)益藥 活血祛瘀藥
Keywords:
femur head necrosis drug therapy(TCD) reinforcing drugs blood act stasis remove drugs
摘要:
目的:分析中醫(yī)藥治療股骨頭壞死(osteonecrosis of the femoral head,ONFH)的常用藥物。方法:以“關(guān)鍵詞=股骨頭壞死 OR 關(guān)鍵詞=股骨頭缺血性壞死 AND 任意字段=中藥 AND 年份=2005-2016”為檢索式,用計(jì)算機(jī)在中國(guó)知網(wǎng)、萬(wàn)方學(xué)術(shù)期刊數(shù)據(jù)庫(kù)、維普中文期刊數(shù)據(jù)庫(kù)檢索相關(guān)期刊文獻(xiàn),在篩選出的文獻(xiàn)中篩選符合要求的中藥并記錄相關(guān)信息。結(jié)果:共檢索出2272篇文獻(xiàn),經(jīng)過(guò)篩選最終納入510篇,其中包括180味中藥,最終納入13味中藥。按其功效分為補(bǔ)虛藥和活血化瘀藥2大類(lèi),補(bǔ)虛藥包括當(dāng)歸、黃芪、續(xù)斷、芍藥、熟地黃、杜仲,活血化瘀藥包括川芎、牛膝、丹參、骨碎補(bǔ)、紅花、乳香、土鱉蟲(chóng)。結(jié)論:補(bǔ)虛藥和活血化瘀藥是中醫(yī)藥治療ONFH的2類(lèi)常用藥物。
Abstract:
Objective:To analyse the drugs commonly used in TCM therapy for treatment of osteonecrosis of the femoral head(ONFH).Methods:The Boolean logical combination of ONFH or avascular necrosis of the femoral head(keyword)and TCM(any field)were used as index terms to retrieve all the periodical literatures from 2005 to 2016 from China national knowledge internet,Wanfang Database and Vip Database of Chinese journal through computer.The literatures were screened and the traditional Chinese drug(TCD)that met the requirements were search out. and their relevant infomation was recorded.Results:A total of 2272 literatures were searched out.After screening,510 literatures were included in the final analysis.A total of 180 TCD were search out from the literatures and 13 TCD were included in the final analysis and they were divided into 2 categories including Buxu(補(bǔ)虛,BX)drugs and Huoxue Huayu(活血化瘀,HXHY)drugs according to their efficacy.The BX drugs included angelica sinensis,astragalus membranaceus,dipsacus asper,paeonia veitchii, radix rehmanniae praeparata and eucommia ulmoides; while the HXHY drugs included ligusticum chuanxiong,achyranthes bidentata,salvia miltiorrhiza,drynaria fortunei,carthamus tinctorius,olibanum and eupolyphaga seu steleophaga.Conclusion:BX drugs and HXHY drugs are used fequently in TCM therapy for treatment of ONFH.

參考文獻(xiàn)/References:

[1] 管紅珍,彭智聰,傅鷹.循證醫(yī)學(xué)中文獻(xiàn)證據(jù)等級(jí)標(biāo)準(zhǔn)的系統(tǒng)性綜述[J].藥物流行病學(xué)雜志,2002,11(3):145-148. [2] 高學(xué)敏.中藥學(xué)[M].2版.北京:中國(guó)中醫(yī)藥出版社,2007. [3] 宋紅梅,吳斌,魏迎辰,等.溫陽(yáng)補(bǔ)腎方對(duì)激素性股骨頭壞死模型兔股骨頭形態(tài)學(xué)的影響[J].中國(guó)中醫(yī)骨傷科雜志,2014,22(3):1-3. [4] 宋紅梅,吳斌,魏迎辰,等.溫陽(yáng)補(bǔ)腎方對(duì)兔激素性股骨頭壞死血清OPG、RANK、RANKL的影響[J].中國(guó)中醫(yī)骨傷科雜志,2013,21(12):1-7. [5] 李曦,張麗宏,王曉曉,等.當(dāng)歸化學(xué)成分及藥理作用研究進(jìn)展[J].中藥材,2013,36(6):1023-1028. [6] Kim YC,Quan FS,Song JM,et al.Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles[J].Procedia in Vaccinology,2010,2(1):17-21. [7] 張波,徐博,吳昊,等.續(xù)斷對(duì)兔骨折愈合過(guò)程中相關(guān)基因表達(dá)和血鈣、磷含量的影響[J].氨基酸和生物資源,2016,38(2):54-57. [8] 張佩,董路玨,李義凱.新傷續(xù)斷湯對(duì)成骨細(xì)胞增殖及骨形態(tài)發(fā)生蛋白的影響[J].廣州中醫(yī)藥大學(xué)學(xué)報(bào),2016,(1):92-97. [9] Zhou Z,Lin J,Huo R,et al.Total glucosides of paeony attenuated functional maturation of dendritic cells via blocking TLR4/5 signaling in vivo[J].Int Immunopharmacol,2012,14(3):275-282. [10] 孟祥龍,馬俊楠,張朔生,等.熟地黃炮制(九蒸九曬)過(guò)程中藥效化學(xué)成分量變化及炮制輔料對(duì)其影響研究[J].中草藥,2016,47(5):752-759. [11] 賈英民,李瑞玉,武密山,等.地黃梓醇對(duì)原代培養(yǎng)SD乳大鼠成骨細(xì)胞成骨活性的影響研究[J].現(xiàn)代中西醫(yī)結(jié)合雜志,2015,24(23):2524-2526. [12] 李三華,劉坤祥,莫寧萍,等.RT-PCR法檢測(cè)杜仲總黃酮對(duì)大鼠成骨細(xì)胞骨鈣素表達(dá)的影響[J].遵義醫(yī)學(xué)院學(xué)報(bào),2011,34(3):223-225. [13] 王日生.活血化瘀中藥藥理作用探析[J].亞太傳統(tǒng)醫(yī)藥,2014,10(4):74-75. [14] 張周.川芎嗪對(duì)心血管保護(hù)的藥理學(xué)作用和臨床應(yīng)用進(jìn)展[J].中國(guó)實(shí)用醫(yī)藥,2009,4(7):129-130. [15] 吳江瑩,吳江雁,劉曉新.五種中藥抗血小板作用機(jī)制及在防治缺血性卒中中的應(yīng)用[J].中西醫(yī)結(jié)合心腦血管病雜志,2015,13(13):1500-1503. [16] 于大永,呂曉超,史麗穎,等.牛膝中三萜皂苷抑制破骨細(xì)胞分化作用的研究[J].中國(guó)中醫(yī)骨傷科雜志,2011,19(3):9-10. [17] 周江濤,王慶來(lái),趙依娜,等.牛膝含藥血清對(duì)骨關(guān)節(jié)炎軟骨細(xì)胞P38絲裂原活化蛋白激酶信號(hào)轉(zhuǎn)導(dǎo)通路的影響[J].中醫(yī)正骨,2012,24(12):15-19. [18] 李曉明,郭東輝,石國(guó)君,等.髓芯減壓聯(lián)合丹參酮ⅡA混合植骨治療FicatⅡ期股骨頭壞死[J].中醫(yī)正骨,2014,26(5):9-12. [19] 上官文姬,李鶴,湯璐敏.骨碎補(bǔ)總黃酮對(duì)大鼠成骨細(xì)胞VEGF和FGF-2表達(dá)的影響[J].遼寧中醫(yī)藥大學(xué)學(xué)報(bào),2014,16(8):38-41. [20] 張琳,沈國(guó)舜,張鏡年,等.羥基紅花黃色素A的血管作用及其機(jī)制研究[J].上海交通大學(xué)學(xué)報(bào):醫(yī)學(xué)版,2009,29(4):431-434. [21] 萬(wàn)甜,吳敏瑞,齊振熙.羥基紅花黃色素A對(duì)激素誘導(dǎo)骨髓間充質(zhì)干細(xì)胞成骨分化的影響[J].中國(guó)骨傷,2014,(3):224-228. [22] 齊振熙,萬(wàn)甜,洪昆達(dá),等.羥基紅花黃色素A對(duì)激素性股骨頭缺血壞死兔股骨頭組織JNK1表達(dá)的影響[J].中華中醫(yī)藥雜志,2014,29(12):3962-3965. [23] 蔣海峰,宿樹(shù)蘭,歐陽(yáng)臻,等.乳香、沒(méi)藥提取物及其配伍對(duì)血小板聚集與抗凝血酶活性的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2011,17(19):160-165. [24] 黃鎮(zhèn)林,何亮穎,王宏濤,等.土鱉蟲(chóng)活性組分F2-2體內(nèi)抗凝藥效實(shí)驗(yàn)[J].世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化,2014,16(6):1359-1363.

相似文獻(xiàn)/References:

[1]白春曉,賈育松,孫旗,等.中醫(yī)藥在腰椎間盤(pán)突出癥圍手術(shù)期應(yīng)用的研究進(jìn)展[J].中醫(yī)正骨,2015,27(11):65.
[2]江建春.神經(jīng)根型頸椎病的中醫(yī)藥治療研究概況[J].中醫(yī)正骨,2015,27(11):71.
[3]田正強(qiáng).消腫止痛散外敷聯(lián)合繃帶固定治療急性踝關(guān)節(jié)扭傷[J].中醫(yī)正骨,2015,27(10):28.
[4]劉枝城,董霞,謝正虎,等.手法整復(fù)小夾板鋼絲托板固定治療兒童新鮮孟氏骨折[J].中醫(yī)正骨,2015,27(10):55.
[5]沈海良,錢(qián)萬(wàn)鋒,周驍棟.針刀松解聯(lián)合局部封閉與口服中藥治療腰椎間盤(pán)突出癥[J].中醫(yī)正骨,2015,27(09):46.
[6]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對(duì)兔股骨頭壞死模型 血管內(nèi)皮生長(zhǎng)因子表達(dá)的動(dòng)態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
 XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):1.
[7]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長(zhǎng)因子和骨形態(tài)發(fā)生蛋白2 在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
 ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[8]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[9]任博文,楊豪.口服桂葛萆薢湯加減配合功能鍛煉治療 寒濕型腰椎間盤(pán)突出癥[J].中醫(yī)正骨,2015,27(08):53.
[10]趙新杰,孫實(shí),武愛(ài)玲.中醫(yī)藥治療膝關(guān)節(jié)滑膜炎的研究進(jìn)展[J].中醫(yī)正骨,2015,27(08):65.
[11]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[12]姚晨,沈計(jì)榮,杜斌,等.口服補(bǔ)腎活血湯聯(lián)合微創(chuàng)保髖術(shù)治療股骨頭壞死腎虛血瘀證的臨床研究[J].中醫(yī)正骨,2016,28(11):7.
 YAO Chen,SHEN Jirong,DU Bin,et al.Clinical study on oral application of Bushen Huoxue Tang(補(bǔ)腎活血湯)combined with minimally invasive hip-preserving surgery for treatment of kidney-deficiency-blood-stasis-type osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):7.
[13]宋夢(mèng)歌,李記天,薛志鵬,等.股骨頭壞死保髖治療的臨床療效分析[J].中醫(yī)正骨,2020,32(01):36.
[14]魏秋實(shí),李子祺,袁穎嘉,等.“標(biāo)本兼治”理論在股骨頭壞死中醫(yī)藥治療中的指導(dǎo)作用[J].中醫(yī)正骨,2020,32(01):56.
[15]顧勇,趙艷明,童培建,等.基于數(shù)據(jù)挖掘法探討中藥復(fù)方治療股骨頭壞死的組方規(guī)律[J].中醫(yī)正骨,2021,33(06):49.
 GU Yong,ZHAO Yanming,TONG Peijian,et al.A study of medication rule of Traditional Chinese Medicine compounds for treatment of osteonecrosis of femoral head based on data mining approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(08):49.
[16]張應(yīng)拴,邢濤,李盛華,等.名中醫(yī)治療股骨頭壞死的用藥規(guī)律分析[J].中醫(yī)正骨,2021,33(09):73.
 ZHANG Yingshuan,XING Tao,LI Shenghua,et al.Experience of prominent TCM doctors An analysis of clinical medication rules of prestigious TCM doctors in treatment of femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(08):73.

備注/Memo

備注/Memo:
基金項(xiàng)目:四川省瀘州市科技局項(xiàng)目[2010-S-15(7/8)] 通訊作者:徐祖健 E-mail:[email protected]
更新日期/Last Update: 1900-01-01